Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate.
Claesson
B A
BA
Department of Infectious Diseases, University of Gothenburg, Sweden.
Schneerson
R
R
Robbins
J B
JB
Johansson
J
J
Lagergard
T
T
Taranger
J
J
Bryla
D
D
Levi
L
L
Cramton
T
T
Trollfors
B
B
D000907:Antibodies, Bacterial / Q000096:biosynthesis*; D001428:Bacterial Vaccines / Q000009:adverse effects / Q000276:immunology*; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae / Q000276:immunology*; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007223:Infant; D013745:Tetanus Toxoid / Q000009:adverse effects / Q000276:immunology*
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D018073:Haemophilus Vaccines; C055753:Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate; D013745:Tetanus Toxoid